|
NSUN2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62492241884138E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.09869890962955E-11 |
| Normal-vs-Stage2 |
7.51870000000876E-05 |
| Normal-vs-Stage3 |
2.65598654181076E-12 |
| Normal-vs-Stage4 |
6.63991084337567E-12 |
| Stage1-vs-Stage2 |
6.767800E-01 |
| Stage1-vs-Stage3 |
1.303720E-02 |
| Stage1-vs-Stage4 |
1.579880E-02 |
| Stage2-vs-Stage3 |
2.193400E-01 |
| Stage2-vs-Stage4 |
2.467200E-01 |
| Stage3-vs-Stage4 |
8.618200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.626032641866E-12 |
| Normal-vs-AfricanAmerican |
4.74649997084242E-09 |
| Normal-vs-Asian |
1.042970E-01 |
| Caucasian-vs-AfricanAmerican |
6.948800E-01 |
| Caucasian-vs-Asian |
8.696000E-01 |
| AfricanAmerican-vs-Asian |
9.632200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.81665793519414E-12 |
| Normal-vs-Female |
5.55111512312578E-16 |
| Male-vs-Female |
9.003800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.775200E-03 |
| Normal-vs-Age(41-60Yrs) |
7.66864349799334E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
4.036200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.565200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.343690E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.137800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.350000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.374400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.749400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.954570E-04 |
| Normal-vs-Grade 2 |
1.69175784492381E-12 |
| Normal-vs-Grade 3 |
2.80789835827022E-11 |
| Normal-vs-Grade 4 |
1.28389965325937E-10 |
| Grade 1-vs-Grade 2 |
8.504000E-01 |
| Grade 1-vs-Grade 3 |
9.515000E-01 |
| Grade 1-vs-Grade 4 |
3.132200E-01 |
| Grade 2-vs-Grade 3 |
4.846600E-01 |
| Grade 2-vs-Grade 4 |
4.277900E-02 |
| Grade 3-vs-Grade 4 |
1.698280E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.50768286744096E-13 |
| Normal-vs-ccB subtype |
3.17189607912383E-11 |
| ccA subtype-vs-ccB subtype |
8.708600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.7803536422889E-12 |
| Normal-vs-N1 |
5.017300E-04 |
| N0-vs-N1 |
2.643800E-01 |
|
|
